SPI1 and Alzheimer disease: Together, these findings reveal a lncRNA-mediated mechanism of PU.1 regulation that shapes microglial inflammatory states and highlight 3222401L13Rik/ENSG00000272070 as potential targets for microglia-oriented therapeutic strategies in Alzheimer’s disease.